CB
Cibus, Inc.
CBUS · NASDAQ
$1.54 -0.65% (-$0.01)
1M -8.33%
Market Cap $117.6M
P/E Ratio -
Div. Yield -
ROE 320.60%
Bulios Fair Price
$1.41
8.4% downside
Trenutna cena
$1.54
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica CBUS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
1 /100
Expensive P/B 7.94x
P/S 27.04x
PEG N/A
Growth
100 /100
Growing Book val. growth 44.51%
Rev. growth 185.12%
FCF growth N/A
Profitability
0 /100
Weak FCF margin 1,065.59%
Op. margin 1,240.90%
Gross margin 383.99%
Quality
0 /100
Poor Asset turnover 0.01x
ROA 31.33%
ROIC 17.82%
Debt
24 /100
High Current ratio 1.62x
Int. coverage -3.33x
Debt/Equity 2.21x
Stability
7 /100
Unstable Profitable years 0
EPS volatility 51,289.58%
Beta 1.59x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CBUS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Craig Wichner
Employees
118
Headquarters
San Diego
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report